TY - JOUR
T1 - Adjuvant effects of cholera toxin B subunit on immune response to recombinant thyrotropin receptor in mice
AU - Fan, Ji Lao
AU - Peterson, Johnny W.
AU - Prabhakar, Bellur S.
N1 - Funding Information:
This work was supported by National Institutes of Health Grants DK47417 and DK44972. We thank Drs Mark Holterman and Mohammed E1 Azami E1 Idrissi for critically reading the manuscript. We thank Dr John Morris for providing the peptides.
PY - 2000/2
Y1 - 2000/2
N2 - We had previously shown that BALB/c mice immunized with the extracellular domain of human thyrotropin receptor (ETSHR) developed moderate hyperthyroxinemia. The antibody responses in these mice were predominantly of the IgG1 subclass. Since cholera toxin B subunit (CT-B) has direct effects on the thyroid, and is known to activate B lymphocytes and cause enhanced IgG1 production, we tested the ability of CT-B to modulate the antibody response to ETSHR. CT-B is unique in that it not only elicits a strong immune response to itself, but more importantly, when given with other antigens acts as a potent adjuvant. In the present study, BALB/c mice given ETSHR with CFA or CT-B via ip route showed higher titers of antibodies to ETSHR when compared to mice similarly immunized with ETSHR alone, or with IFA. Antibodies in ETSHR+CT-B immunized mice were mostly of the IgG1 subclass and reacted predominantly with ETSHR peptides 1 (aa 22-41), 21 (aa 322-341), and 23 (352- 371). In contrast, animals immunized with ETSHR+CFA showed IgG1, IgG2a and IgG2b responses and reacted with peptides 1 and 21. Furthermore, mice immunized with ETSHR along with CT-B showed significantly higher levels of thyrotropin (TSH) binding inhibitory immunoglobulins (TBII) compared to those that did not receive CT-B. None of the mice immunized with a control antigen showed antibody response to ETSHR. These results suggested that CT-B could enhance and modulate immune response to ETSHR.
AB - We had previously shown that BALB/c mice immunized with the extracellular domain of human thyrotropin receptor (ETSHR) developed moderate hyperthyroxinemia. The antibody responses in these mice were predominantly of the IgG1 subclass. Since cholera toxin B subunit (CT-B) has direct effects on the thyroid, and is known to activate B lymphocytes and cause enhanced IgG1 production, we tested the ability of CT-B to modulate the antibody response to ETSHR. CT-B is unique in that it not only elicits a strong immune response to itself, but more importantly, when given with other antigens acts as a potent adjuvant. In the present study, BALB/c mice given ETSHR with CFA or CT-B via ip route showed higher titers of antibodies to ETSHR when compared to mice similarly immunized with ETSHR alone, or with IFA. Antibodies in ETSHR+CT-B immunized mice were mostly of the IgG1 subclass and reacted predominantly with ETSHR peptides 1 (aa 22-41), 21 (aa 322-341), and 23 (352- 371). In contrast, animals immunized with ETSHR+CFA showed IgG1, IgG2a and IgG2b responses and reacted with peptides 1 and 21. Furthermore, mice immunized with ETSHR along with CT-B showed significantly higher levels of thyrotropin (TSH) binding inhibitory immunoglobulins (TBII) compared to those that did not receive CT-B. None of the mice immunized with a control antigen showed antibody response to ETSHR. These results suggested that CT-B could enhance and modulate immune response to ETSHR.
KW - Autoimmunity
KW - Cholera toxin
KW - Graves' disease
KW - Thyrotropin receptor
UR - http://www.scopus.com/inward/record.url?scp=0033951023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033951023&partnerID=8YFLogxK
U2 - 10.1006/jaut.1999.0336
DO - 10.1006/jaut.1999.0336
M3 - Article
C2 - 10648115
AN - SCOPUS:0033951023
SN - 0896-8411
VL - 14
SP - 43
EP - 52
JO - Journal of Autoimmunity
JF - Journal of Autoimmunity
IS - 1
ER -